BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22968075)

  • 21. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
    Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H
    Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medullary thyroid carcinoma metastatic to skin.
    Nashed C; Sakpal SV; Cherneykin S; Chamberlain RS
    J Cutan Pathol; 2010 Dec; 37(12):1237-40. PubMed ID: 19615004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients.
    Kazaure HS; Roman SA; Sosa JA
    Cancer; 2012 Feb; 118(3):620-7. PubMed ID: 21717441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
    Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
    Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
    Haigh PI; Urbach DR; Rotstein LE
    Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of lateral lymph node metastases in medullary thyroid cancer.
    Machens A; Hauptmann S; Dralle H
    Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    Machens A; Lorenz K; Weber F; Dralle H
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
    Farahati J; Mörtl M; Reiners C
    Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
    Mathonnet M
    Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
    Pomorski L; Rybinski K
    Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medullary thyroid carcinoma in Hong Kong Chinese patients.
    Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
    Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of life expectancy in medullary thyroid cancer: age does not matter.
    de Groot JW; Plukker JT; Wolffenbuttel BH; Wiggers T; Sluiter WJ; Links TP
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):729-36. PubMed ID: 17121523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.